1.
Antonio-Villa NE, Bello-Chavolla OY, Fermín-Martínez CA, et al. Diabetes subgroups and sociodemographic inequalities in Mexico: a cross-sectional analysis of nationally representative surveys from 2016 to 2022. Lancet regional health. Americas. 2024;33:100732. doi:10.1016/j.lana.2024.100732.
1.
Mercader JM, Liao RG, Bell AD, et al. A Loss-of-Function Splice Acceptor Variant in Is Protective for Type 2 Diabetes. Diabetes. 2017;66(11):2903-2914. doi:10.2337/db17-0187.
1.
Baran Y, Pasaniuc B, Sankararaman S, et al. Fast and accurate inference of local ancestry in Latino populations. Bioinformatics. 2012;28(10):1359-67. doi:10.1093/bioinformatics/bts144.
1.
Banerji S, Cibulskis K, Rangel-Escareño C, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012;486(7403):405-9. doi:10.1038/nature11154.
1.
Consortium STD 2, Williams AL, Jacobs SBR, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature. 2014;506(7486):97-101. doi:10.1038/nature12828.
1.
Consortium STD 2, Estrada K, Aukrust I, et al. Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population. JAMA. 2014;311(22):2305-14. doi:10.1001/jama.2014.6511.